Mitochondrial distribution in cells is critical for cellular function and proper inheritance during cell division. In mammalian cells, mitochondria are transported predominantly along microtubules by kinesin and dynein and along actin filaments by myosin. Myosin XIX (Myo19) associates with the outer mitochondrial membrane, but no specific receptor has been identified. Using proximity BioID labeling, we identified Miro-1 and Miro-2 as potential binding partners of Myo19. Interaction studies show that Miro-1 binds to a Cterminal fragment of the Myo19 tail region and that Miro recruits the Myo19 tail in vivo. This recruitment is regulated by the nucleotide-state of the N-terminal Rho-like GTPase domain of Miro. Notably, Myo19 protein stability in cells depends on its association with Miro. Finally, Myo19 regulates the subcellular distribution of mitochondria. Downregulation, as well as overexpression, of Myo19 induces perinuclear collapse of mitochondria, phenocopying the loss of kinesin KIF5 or its mitochondrial receptor Miro.
INTRODUCTION
Mitochondria are dynamic organelles that can fuse with each other, divide, or move along cytoskeletal tracks, and make functional contacts with other membranous compartments (Friedman and Nunnari, 2014) . Interfering with this dynamic behavior impairs mitochondrial function, and may lead to a multitude of mostly degenerative diseases (Nunnari and Suomalainen, 2012; Mishra and Chan, 2014) .
In cells, mitochondria are constantly transported to sites where they are needed. This transport occurs either along actin filaments or microtubules depending on the organism.
In animal cells, mitochondria are predominately hauled bidirectionally along microtubules. The microtubule-based motor kinesin-1 (KIF5) transports mitochondria towards the plus-end of microtubules that usually points towards the cell periphery (Tanaka et al., 1998) . KIF5 is recruited to mitochondria with the help of adaptor proteins (Stowers et al., 2002) , which mediate the binding to the outer mitochondrial membrane protein Miro (Miro-1 and Miro-2 in vertebrates). Miro encompasses a C-terminal transmembrane domain and two EF-hand or ELM domains that are in turn flanked by two GTPase domains (Fransson et al., 2003; Klosowiak et al., 2013;  see also supplementary figure S1). The N-terminal GTPase domain shares similarity with the Rho-subfamily of monomeric GTPases. An adaptor protein that links KIF5 with Miro was first identified in Drosophila (Glater et al., 2006) . Subsequently, two mammalian homologues, TRAK1 (OIP106) and TRAK2 (GRIF-1), were identified as adaptors and shown to mediate bidirectional microtubule-dependent transport of mitochondria (Brickley et al., 2005; Fransson et al., 2006; McAskill et al., 2009; Koutsopoulos et al., 2010; Brickley and Stephenson, 2011; van Spronsen et al., 2013) . Transport of mitochondria towards the microtubule minus-ends is mediated by the dynein/dynactin complex. This complex similarly interacts with the adaptors TRAK1 and TRAK2 (van Spronsen et al., 2013; Gama et al., 2017) . The microtubule-dependent transport of mitochondria can be arrested by the binding of Ca 2+ to the EF-hands of Miro (Saotome et al., 2008; MacAskill et al., 2009b; Cai and Sheng, 2009; Wang and Schwarz, 2009) . A point mutation in the N-terminal GTPase domain of Miro that is predicted to favor the GDP-bound state, revealed that this domain is essential for mitochondrial transport and morphology (Fransson et al., 2003; Babic et al., 2015) . However, it is currently not known whether this GTPase domain cycles between different nucleotide-bound states under physiological conditions. The protein Alex3 of the Armcx genes also regulates mitochondrial movements, in neurons, by an interaction with the Miro/TRAK2 complex and this interaction is abrogated by Ca 2+ -binding to the EF-hands of Miro (Lopéz-Doménech et al., 2012) . In addition, Miro can recruit the protein CenpF, and thereby contributes to the mitotic redistribution of mitochondria (Kanfer et al., 2015) . The proteins Mitofusin 1/2, DISC1 and APC are yet other proteins that were reported to interact with the Miro/TRAK complex (Misko et al., 2010; Norkett et al., 2015; Mills et al., 2016) . The protein hypoxia up-regulated mitochondrial movement regulator (HUMMR) was shown to interact directly with Miro (Li et al., 2009) . Importantly, Miro is also a substrate for the E3 ubiquitin ligase Parkin that targets it for proteasomal degradation (Sarraf et al., 2013) .
Mutations in Parkin have been associated with Parkinson disease (Kitada et al., 1998) .
Actin filaments in mammalian cells critically contribute to mitochondrial fission.
The ER-associated formin INF2 in combination with a mitochondria-associated splice form of the actin nucleator Spire and the filament forming motor myosin II are involved in constricting mitochondria to initiate their fission (Korobova et al., 2013 (Korobova et al., , 2014 Manor et al., 2015; Ji et al., 2015) . Additionally, actin filaments serve as tracks for mitochondrial movement. The actin-based motor myosin XIX (Myo19) is associated with mitochondria and when overexpressed induces the formation of motile tadpole-shaped mitochondria (Quintero et al., 2009 ). Downregulation of Myo19 interferes with the proper partitioning of mitochondria during mitosis, leading to a stochastic failure in cell division (Rohn et al., 2014) . Myo19 consists of a head, light chain binding and tail domain (see supplementary figure S1). In vitro studies revealed that the head domain is a plus-end directed motor that is firmly attached to F-actin for most of the time of its chemo-mechanical cycle (Lu et al., 2014) . The tail domain, on the other hand, specifies its recruitment to mitochondria (Quintero et al., 2009) . A short motif in the tail domain (amino acids 860-890) is able to mediate binding to the lipids of the outer mitochondrial membrane (Shneyer et al., 2016; Hawthorne et al., 2016) . However, it is not known how targeting specificity to the outer mitochondrial membrane is achieved and whether there is any coordination between actin-and microtubule-based movements of mitochondria.
In the present study, we attempted to gain further insight into the functions of Myo19 by investigating the molecular mechanism(s) of its recruitment to mitochondria.
Interestingly, Myo19 shares its mitochondrial receptor with kinesin (KIF5) and dynein that potentially allows for a coordination of actin-and microtubule-based mitochondrial movements. A preliminary account of this work has been published in the form of an abstract (Mol. Biol. Cell 2016 27:25 3947, P947; doi:10.1091/mbc.E16-10-0736).
RESULTS

Miro is a mitochondrial receptor of Myo19
To identify potential mitochondrial receptors for Myo19, we used tail proximitydependent biotinylation (BioID) (Roux et al., 2012) , since the tail region contains the mitochondrial targeting information and localizes to mitochondria (Quintero et al., 2009 ).
We generated a stably transfected HeLa cell clone that expressed low levels of the fusion protein BirA*-Myo19 tail when incubated with sodium-butyrate ( Fig. 1 A, B ).
Biotinylated proteins were affinity purified by magnetic streptavidin-beads and analysed by mass spectrometry (Table1). Thereby, we identified peptides from Miro-1 and Miro-2, the mitochondrial receptors for microtubule-based transport. Immunoblotting experiments further demonstrated that Miro, but not the outer mitochondrial membrane protein VDAC-1, was biotinylated specifically by BirA*-Myo19 tail. Miro was eluted after affinity purification from streptavidin exclusively upon expression of the BirA*-Myo19 tail construct ( Fig. 1 C, D) . In accordance with our results, Miro-2 has recently been identified as a binding partner of Myo19 in two independent large-scale protein-protein interaction screens (Huttlin et al., 2015; Hein et al., 2015) . A few additional outer mitochondrial membrane proteins were discovered in the Myo19-tail BioID screen, namely metaxin-3, AKAP1 and MAVS (Table1). Subsequently, we focused on Miro proteins and tested whether Myo19 interacts with Miro1 directly (Fig. 2) . We expressed and purified C-terminally His-tagged recombinant human Miro1 lacking its transmembrane domain (Miro1-ABC, aa 1-592; Klosowiak et al., 2016 ) ( Fig. 2A ). As a potential binding partner, we expressed and purified a FLAG-tagged C-terminal tail fragment (aa 898-970-FLAG) of human Myo19 that lacks the more N-terminally located lipid-binding motif ( Fig. 2A) . The purified Myo19 C-tail fragment still contained a major contaminant protein of approx. 70 kD from E. coli. Pull-down experiments were performed with Miro1 adsorbed to Talon beads. The Myo19 C-tail fragment was eluted specifically together with Miro, but not from control beads lacking Miro1-ABC ( Fig. 2B ), indicating that this Myo19 tail fragment interacts directly with Miro1.
To test for potential involvement of Miro in the localization of Myo19 to mitochondria, we downregulated Miro (Miro-1 and Miro-2) by siRNA in HeLa cells. Notably, the downregulation of Miro resulted in a concomitant downregulation of Myo19 as revealed by immunoblotting ( Fig. 3A-D) . This drop in Myo19 protein was not due to a general reduction in mitochondrial mass, as the signal for the outer mitochondrial membrane protein VDAC-1 was not affected by downregulation of Miro ( Fig. 3 A, B ). Transfection of cells with either pools or individual siRNAs directed against Miro-1 and Miro-2 led to time-dependent downregulation of Miro, with clear reduction after 48 h and 72 h (approx. 85 % reduction) ( Fig. 3 A, B) . Notably, the downregulation of Miro was accompanied by comparable time-dependent downregulation of Myo19 (approx. 70 % after 72 h). The concomitant downregulation of Myo19 with Miro could be attenuated by transient overexpression of Miro2 resistant to the siRNA ( Fig. Fig. 3 B, D) . Conversely, downregulation of Myo19 with siRNA did not alter the expression of Miro ( Fig. 3 A, C) .
These results strongly argue that Miro stabilizes Myo19, but that contrariwise Myo19 does not influence the stability of Miro. Indirect immunofluorescence labeling of Myo19 in cells treated with siRNA against Miro1 and 2 confirmed that the amounts of Myo19 protein associated with mitochondria depended on the expression of Miro (Fig. 3E ). The mitochondrial signal of Myo19 was greatly reduced in cells that had Miro downregulated.
To verify that Miro indeed regulates Myo19 protein stability, pulse-chase experiments were performed with Halo-tagged Myo19. Stable cell lines expressing Halo-tagged Myo19 were incubated with siRNA directed against Miro and the Halo-tag of Myo19 protein was pulse-labeled with the fluorophore TMR. Labeled Myo19 decayed faster when simultaneously Miro was being downregulated ( Fig. 3 F) . Interestingly, Myo19 protein turnover was slower when the Halo-tag was fused to the C-terminus ( Fig. 3G ).
This was the case irrespective of whether the cells were treated with non-targeting control siRNA or Miro1 and 2 siRNA. These data reveal that the positioning of the tag influences the life-time of Myo19 protein and that Miro increases the life-time of Myo19 protein.
Further evidence that release of Myo19 from mitochondria promotes its degradation was provided by the observation that stable expression of BirA*-Myo19 tail displaced endogenous Myo19 from mitochondria without corresponding increase of Myo19 protein in the cytosol fraction ( Fig. 4 ). Analysis of cell homogenates confirmed that Myo19 gets degraded upon overexpression of Myo19 tail (Suppl. Fig. S2 ).
Additionally, the overexpression of BirA*-Myo19 tail led to a slight reduction of the amount of TRAK1 that was associated with purified mitochondria. However, the reduction of this adaptor molecule for KIF5B and dynein was not significant (Fig. 4) .
The simultaneous downregulation of Myo19 with Miro precluded a meaningful analysis of potential redistribution of Myo19 in the absence of Miro. The proportion of background signal significantly increased in relation to the specific signal, so that no meaningful quantification of the remaining mitochondrial localization of Myo19 was possible (see Fig. 3E ). Therefore, we devised an alternative strategy to test for in vivo recruitment of Myo19 by Miro. We retargeted Miro 1 to early endosomes by replacing its C-terminal transmembrane domain with 2xFYVE domains that mediate binding to phosphatidylinositol-3-phosphate (see schematic representation suppl. Fig. S1 ). This Miro construct was indeed targeted to early endosomes as it colocalized with fluorescently labeled transferrin that was taken up by receptor-mediated endocytosis (Suppl. Fig. S3A ). To monitor retargeting of the Myo19 tail that directs Myo19 to mitochondria (Quintero et al., 2009; see also Fig. 4 ) and to delineate the mitochondrial and Miro binding site(s) in the Myo19 tail region more precisely, we analysed various fragments of the Myo19 tail region for Miro-dependent retargeting to early endosomes.
We found that the tail region of Myo19 localized both to mitochondria with endogenous Miro and to early endosomes with retargeted Miro-1 ( Fig. 5 A-C), indicating that Miro is sufficient for the specific recruitment of Myo19 tail in vivo. An N-terminal tail fragment (aa 824-897) encompassing a reported lipid-binding domain (Shneyer et al., 2016; Hawthorne et al., 2016) localized exclusively to mitochondria and was not redirected to early endosomes ( Fig. 5 A-C). In contrast, the C-terminal tail fragment (aa 898-970) that bound to Miro-1 in vitro colocalized with Miro that was retargeted to early endosomes ( Fig. 5 A-C). Part of this C-terminal tail fragment was also found in the cytosol, but it was not obviously colocalized with mitochondria ( Fig Fig. S2B ).
Myo19 regulates the subcellular distribution of mitochondria
In mammalian cells, the subcellular distribution of mitochondria is regulated by microtubule-based motor proteins and their mitochondrial receptor Miro (Maeder et al., 2014; Mishra et al., 2016) . The silencing of either Miro or Kif5 protein expression has been shown to induce perinuclear accumulation of mitochondria (Tanaka et al., 1998; Liu et al., 2012) . To analyze whether Myo19 contributes to mitochondrial distribution in cells, we either silenced or overexpressed Myo19 in HeLa cells. We specifically measured the perinuclear accumulation factor of mitochondria in cells, which we defined as the percentage of mitochondria within the perinuclear region, divided by the fraction of the cell area occupied by this region. This quantification confirmed that depletion of Miro1+2 or Kif5B with siRNAs causes significant perinuclear accumulation of mitochondria ( Fig. 6 ). Interestingly, siRNA-mediated depletion of Myo19 expression also significantly shifted the localization of mitochondria to the perinuclear region ( Fig. 6 ).
Next, we addressed if overexpression of Myo19 or different tail fragments would affect mitochondrial distribution. We found that overexpression of GFP-Myo19 phenocopied the effect of Myo19 downregulation (Fig. 7 ). This effect was independent of the actinbased motor capacity of Myo19, since the GFP-labeled tail region of Myo19, when overexpressed, induced an even more pronounced perinuclear accumulation of mitochondria ( Fig. 7) . Overexpression of the Myo19 C-tail fragment that has been shown to interact with Miro also induced perinuclear accumulation of mitochondria (Fig. 7) . The N-tail lipid-binding fragment might still compete to some extent for binding of endogenous Myo19 to mitochondria, as its overexpression caused a less pronounced, but still significant, perinuclear accumulation of mitochondria ( Fig. 7) . To exclude that the perinuclear accumulation of mitochondria was due to oligomerization of the fused EGFP label, the experiments were repeated with full-length Myo19 and Myo19 tail, respectively, that were fused with a Halo tag and labeled with TMR. These experiments confirmed that the perinuclear accumulation of mitochondria occurred independently of EGFP, and again showed that the tail region of Myo19 has a stronger effect on mitochondrial distribution than full-length Myo19 (Fig. 8 ). We also assessed whether overexpression of Myo19 or tail fragments thereof led to a change in cell size or shape.
Such changes might impact the quantification of perinuclear clustering. We found that cells overexpressing full-length Myo19 covered a smaller area, had a shorter perimeter and increased circularity (Suppl. Fig. S4 ). However, this effect seemed to be dependent on the motor domain of Myo19, since none of the Myo19 tail fragments caused similar changes when overexpressed (Suppl. Fig. S4 ). In cells overexpressing EGFP-tail, for which the most pronounced perinuclear accumulation of mitochondria had been observed, the perinuclear accumulation factors were only weakly correlated to the cell size and shape as assessed by Pearson's correlation coefficient. The strongest correlation was found between a cell's perinuclear accumulation factor and its covered area or perimeter (R = 0.46 and 0.43, respectively). This positive correlation rather confirmed than invalidated the observed increased perinuclear accumulation of mitochondria in the smaller Myo19-overexpressing cells, since increased perinuclear clustering in smaller cells would actually be detected less readily. In summary, both the downregulation of Myo19 and the overexpression of full-length Myo19 or Myo19 tail fragments that contain the Miro-binding site induced perinuclear clustering of mitochondria.
DISCUSSION
In this study we identified Miro (comprising Miro-1 and Miro-2) as a mitochondrial receptor for Myo19 and showed that this interaction stabilizes Myo19, but not Miro. We further found that both downregulation of Myo19 and overexpression of Myo19 or Mirobinding Myo19 fragments phenocopy the loss of both Miro and the microtubule-based motor KIF5. KIF5-dependent transport of mitochondria towards the plus-end of microtubules and dynein-dependent transport to the opposite end are mediated by the protein Milton/TRAK that serves as an adaptor for Miro and both KIF5 and dynactin/dynein (Glater et al., 2006; van Spronsen et al., 2013) . Although we could demonstrate a direct interaction between Myo19 and Miro, it remains to be determined whether TRAK or another adaptor protein modulates this interaction. This will be an important issue for the future to unravel the coordination between microtubule-and actin-based mitochondrial movements. The perinuclear collapse of mitochondria (Chan et al., 2011; Wang et al., 2011) . Additionally, the degradation of Miro-2 is regulated by the PGAM5-KEAP1-Nrf2 complex. Miro-2, but not Miro-1, is a substrate for KEAP1-cullin-3 E3 ubiquitin ligase and the proteasome (O'Mealey et al., 2017) . Following Miro degradation by either pathway, microtubule-based mitochondrial movement is halted (Wang et al., 2011; O'Mealey et al., 2017) .
Similarly, actin-based motility by Myo19 will be abrogated by loss of Miro. In agreement with our work, Lopez-Domenech et al. (2018) reported, while this work was in revision that Miro stabilizes Myo19 on mitochondria. A remarkable analogy represents vacuole inheritance in S. cerevisiae that relies on actin-based transport by the class V myosin Myo2. Unloading of the vacuole at its proper destination from Myo2 is controlled by the degradation of its vacuole adapter Vac17 (Yau et al., 2017) .
Recently, it has been reported that a peptide encompassing residues 860-890 in the tail region of Myo19 serves as an outer mitochondrial membrane-binding motif (Shneyer et al., 2016; Hawthorne et al., 2016) . This finding agrees well with our observation that a Nterminal tail fragment (aa 824-897) of Myo19 is able to localize to mitochondria.
However, this lipid-binding motif alone appears not to provide sufficient specificity and functionality under physiological conditions. To establish specificity and fully functional association with mitochondria, Myo19 has to interact additionally with Miro. Although the overexpressed Myo19 Miro-binding motif appeared to be localized mainly in the cytosol, it induced perinuclear collapse of the mitochondria, indicating that it successfully competed with other proteins for binding to Miro. An increase of the Miro concentration resulted in the distinct recruitment of the Miro binding C-terminal tail fragment (aa 898-970) of Myo19 to mitochondria (data not shown). Miro was not only necessary, but also sufficient to recruit the Myo19 tail. When Miro was redirected to early endosomes, the Myo19 tail was also localized on early endosomes. Furthermore, this result demonstrates the predominance of the interaction with Miro over the lipid binding by Myo19.
We showed here that the N-terminal Rho-like GTPase domain of Miro is critically involved in the recruitment of Myo19. Currently, there is no conclusive evidence available as to whether this domain cycles between a GDP-and a GTP-bound state in vivo. Based on sequence comparisons, it appears likely that this domain in Miro has GTP bound constitutively, and is not cycling, since some residues important for hydrolysis are not conserved (Longenecker et al., 2003; Fransson et al., 2003; Li et al., 2002; Foster et al., 1996; Nobes et al., 1998) . Marginal GTPase activity has been reported for this domain in Gem1p, the yeast analog, with one GTP hydrolysed in 5-10 min (Koshiba et al., 2011) . Phosphorylation of a serine residue was recently suggested to increase GTPase activity (Lee et al., 2016) . Mutation in Miro of a threonine residue at the end of the P-loop that is conserved in nucleotide binding proteins to asparagine (T18N) abrogated the recruitment of Myo19. Introduction of the analogous mutation (T19N) in RhoA produces a dominant negative form. This RhoA mutant has an accelerated rate of GTP hydrolysis, but is mostly in a nucleotide free state exhibiting a high affinity for guanine nucleotide exchange factors (Strassheim et al., 2000; Miyazaki et al., 2002) . Genetic experiments in Drosophila with this Miro mutant suggested that it is essentially a recessive loss-of-function mutation (Babic et al., 2015) . Residues mutated in dominant active constructs of RhoA are not conserved in Miro-1. Therefore, it is not certain whether the corresponding mutations in Miro-1 will induce similar alterations.
Neuronal phenotypes observed for one such point mutation in Drosophila (dMiroA20V) were not compatible with a constitutively active mutation (Babic et al., 2015) . It remains to be determined whether cycling between different nucleotide states of the N-terminal GTPase domain of Miro represents a physiological mechanism to regulate Myo19 recruitment. The protein VopE from the bacterial pathogen Vibrio cholerae has been proposed to act as a GTPase-activating protein (GAP) for the N-terminal GTPase domain of Miro and the mammalian protein RAP1GDS1 as a guanine-nucleotide exchange factor (GEF) (Ding et al., 2016) .
Myo19 was shown to regulate the subcellular distribution of mitochondria. Both, downregulation and overexpression of Myo19 induced a perinuclear accumulation of mitochondria. A similar perinuclear accumulation of mitochondria was observed in the absence of Miro which negatively affected cytoplasmic energy distribution, cell migration and cell adhesion (Schuler et al., 2017) . During cell division, Myo19 regulates the allocation of mitochondria to daughter cells. Loss of Myo19 causes asymmetric partitioning of the mitochondria to one or both spindle poles in mitosis and stochastic failure of cytokinesis (Rohn et al., 2014) . In contrast, in the presence of Myo19, mitochondria do not localize to spindle microtubules, but instead are localized in the periphery (Lee et al., 2007; Chung et al., 2016) . Forced attachment of dynein or kinesin motors to the mitochondrial surface during mitosis generates a phenotype comparable to that observed after downregulation of Myo19 (Chung et al., 2016; Rohn et al., 2014) .
MATERIALS AND METHODS
Reagents and antibodies
The antibodies used were as follows: Myo19 (EPR12551-13/ab174286, Abcam, WB: 1:1000; HPA021415, Sigma-Aldrich); Miro-1/2 (NBP1-59021, Novus Biologicals, WB: 1:4000); KIF5B (ab167429; Abcam, WB: 1:1000); TRAK1 (PA5-44180, Thermo Fisher, WB: 1:1000); VDAC1 (20B12AF2/ab14734, Abcam, WB: 1:1000); myc (ab9106, Abcam, WB: 1: 25,000); GAPDH (TA802519; OriGene); β-actin (AC-15/A1978, Sigma-Aldrich, Falasca, London, UK (Maffucci et al., 2003) . The plasmid mCherry-Miro-1-ΔTM-2xFYVE
Construction of plasmids
has the sequences coding for amino acid residues 592-618 of Miro-1 replaced by the sequences coding for 2xFYVE domains. The plasmid coding for the fusion protein pmCherry-Miro-1-aa1-408-2xFYVE was constructed by standard molecular biology techniques. The pET28a(+) plasmid encoding hMiro1-ABC(aa1-592)-6xHis was a kind gift of S.E. Rice (Chicago, USA) (Klosowiak et al. 2016) . The plasmid encoding the mitochondrial targeting sequence from the subunit VIII of the human cytochrome c oxidase fused to RFP was purchased from BD Pharmingen and the sequence coding for RFP was exchanged for EGFP and mCherry, respectively. Plasmid mTagBFP2-TOMM20-N-10 was a gift from Michael Davidson (Addgene plasmid # 55328) (Subach et al., 2011) . All fragments amplified by PCR were sequenced. Single colonies of cells were isolated with a metal ring, trypsinized and transferred to 6well-plates. Cells were processed for western blot analysis and further expansion.
Cell culture and transfection of HeLa cells
For knockdown studies of Miro-1 and Miro-2, 100,000 HeLa cells per well were seeded in 6-well-plates. The following day, cells in one well were transfected with 25 pmol of each siRNA or each pool of 4 siRNAs that was mixed with 7.5 µl Lipofectamine
RNAiMAX in 183 µl DMEM. Cells were harvested for western blot analysis 48 h and 72 h after transfection.
BioID
BioID was carried out essentially as described in Roux et al. (2013) 
Pull-down assay
Purified hMiro1-ABC was loaded with GTP by adding 2 mM GTP and 6 mM EDTA for 10 Protein concentrations were determined by Bradford assay using BSA as a standard.
Equal amounts of protein were separated by SDS-PAGE and further processed for immunoblotting. 
Pulse-chase experiments
Mitochondria purification
Prior to mitochondria purification, HeLa wt and HeLa myc-BirA* Myo19 tail cells were treated overnight with 10 mM Na-butyrate. Mitochondria were purified with Qproteome Mitochondria Isolation Kit (QIAGEN) according to the manufacturers protocol for highpurity mitochondria.
Fluorescence stainings
To label mitochondria, cells were incubated with 75 nM MitoTracker Red CMXRos 
Transferrin endocytosis assay
HeLa cells grown on coverslips were serum-starved for 30 min in MEM medium at 37 °C, 5 % CO 2 and 95 % humidity. AF 488-conjugated human transferrin (30 µg/ml) (ThermoFisher) in MEM medium was added for 1 h at 37 °C. Cells were washed with ice cold 1x PBS and subsequently fixed with 4 % PFA for 20 min at RT.
Retargeting and quantification
HeLa cells were fixed 24 h after transfection and analysed by spinning disk microscopy (UltraVIEW VoX, PerkinElmer; Nikon Eclipse Ti). Images were acquired with a 60x/1.49 NA oil objective and an EMCCD camera using Volocity software. Z-stacks covering the entire depth of cells with intervals of 0,5 µm were acquired. To quantify retargeting of tail constructs to early endosomes maximum intensity projections were obtained using ImageJ. To separate mitochondria from background a "top hat" filter was applied.
Pearson's correlation coefficient was used to express the intensity correlation of colocalizing objects. Analysis was restricted to custom ROI of each cell, with a thresholding factor of 2. The result is +1 for perfect correlation, 0 for no correlation, and -1 for perfect anti-correlation.
Mitochondria distribution
Imaging
To assess mitochondria distribution, 20'000 HeLa cells per well were plated on glass coverslips in 24-well plates. The next day, cells were transfected with appropriate plasmids using the transfection reagent Lipofectamine TM LTX and PLUS TM reagent (Invitrogen) according to the manufacturer's instructions. 24 h after transfection, the cells were processed further: Cells that had been transfected with Halo constructs were labelled with 5 µM HaloTag® TMR ligand (Promega) in full medium for 30 min at 37 °C, followed by several washing steps with PBS and full medium before fixation. Cells were washed with PBS and fixed with 4% PFA, stained for DNA with DAPI and, if appropriate, for F-actin with fluorophore-labelled phalloidin, mounted on microscope slides and left to harden at 4 °C overnight. For experiments involving protein depletion, 100'000 HeLa cells per well were seeded in 6-well plates. 24 h after seeding, the cells were transfected with appropriate siRNAs using the transfection reagent Lipofectamine TM RNAiMAX according to the manufacturer's instructions. The next day, the cells were replated into 24 well plates and transfected, fixed and stained as described above. Imaging was performed with a 63x N.A. 1.4 Plan-Apochromat oil immersion objective on a Zeiss LSM 510 confocal laser scanning microscope equipped with Argon and Helium-Neon lasers and three 12-bit R/FI detectors. Z-stacks of mitochondria and, if appropriate, other labeled structures were recorded at a plane interval of 0.5 µm; upper and lower boundaries of the stacks were set manually for each field of view. Bright-field images were recorded with 12-bit R/FI detectors along with the z-stacks. DAPI fluorescence was excited with a mercury vapor short-arc HBO 50 lamp and detected with an 8-bit
AxioCam MRm camera.
Analysis
Image processing and analysis were performed in ImageJ (NIH, USA) with customized macros. Briefly, z-stacks of fluorescence channels were converted to sum projections, and sum projections of the mitochondria were top-hat filtered and background corrected.
Size and orientation of the DAPI images were adjusted to the confocal images. For each cell, the outline was determined manually based on the bright-field image. Shape descriptors routinely available in ImageJ were measured for the cell outline. The nucleus outline was determined via automated thresholding of the DAPI image and was dilated to determine the boundary of the perinuclear region, which was defined as a 4 µm wide ring around the nucleus. When the dilated nucleus outline exceeded the cell outline, it was cut accordingly. For each of the cell's regions (in/above/below nucleus, perinuclear, peripheric), the proportion of mitochondria signal was measured as well as the fraction of the total cell area occupied by this region. The perinuclear mitochondria accumulation factor was defined as the proportion of mitochondrial signal within the perinuclear region, divided by the fraction of the total cell area occupied by the perinuclear region.
Statistical evaluation
Data are displayed as box plots with the box ranging from 25 th to 75 th percentiles, whiskers ranging from 10 th to 90 th percentiles, the median marked as a line, and the mean marked as a square. Data were analyzed by non-parametric statistical tests; the significance levels were set to p ≤ 0.05 (*), p ≤ 0.01 (**), and p ≤ 0.001 (***). 
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